医学
指南
胆固醇
血胆固醇
国家胆固醇教育计划
内科学
心血管事件
初级预防
他汀类
心脏病学
不利影响
重症监护医学
家庭医学
代谢综合征
心肌梗塞
病理
肥胖
疾病
作者
Sarah Chuzi,Anna Pfenniger,Donald M. Lloyd‐Jones,Roger S. Blumenthal,Sidney C. Smith,Salim S. Virani,Scott M. Grundy,Neil J. Stone
出处
期刊:JAMA Cardiology
[American Medical Association]
日期:2019-04-10
卷期号:4 (5): 473-473
被引量:1
标识
DOI:10.1001/jamacardio.2019.0771
摘要
These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines.
科研通智能强力驱动
Strongly Powered by AbleSci AI